Symrise’s New Partnership Provides Peptides to the Cosmetics Industry

HOLZMINDEN, Germany--Symrise, a supplier of fragrances, active cosmetic ingredients and flavorings, has acquired a 20 percent stake in the U.S. biotechnology company Therapeutic Peptides Inc. (TPI), thus securing exclusive distribution rights for highly advanced cosmetic active ingredients.

In acquiring a stake in TPI, Symrise will have access to an innovative group of active ingredients known as peptides, which the company can immediately offer to its customers in the international cosmetics industry. Peptides are used as anti-microbial substances, in anti-aging skin care products, and to stimulate hair growth. "It is only just recently that peptides have been used in cosmetic products. We are delighted to be able to integrate these modern and very effective ingredients in our portfolio,” said Dr. Klaus Stanzl, President Scent & Care, Life Essentials. “With TPI, we have found a partner who is developing these ingredients at a scientifically exalted level and can offer ample expertise in this field," In connection with the Symrise shareholding in TPI, Stanzl has also been elected to its supervisory board.

With the Symrise stake, TPI, the Louisiana-based company, will have fresh resources available for maintaining its intensive research work. "Symrise is for us the ideal partner. It opens up worldwide distribution opportunities for our substances," said Dr. Donald Owen, founder and managing director, TPI.

Symrise’s stake in TPI represents a further, strategically wise expansion of its portfolio of cosmetic ingredients. Exclusive distribution of modern and highly efficient peptides, whose effectiveness is scientifically proven, will enable the company to react to the growing demand from its customers in this field.

(Source: Symrise)